Coronary Artery Calcium Scoring to Guide Prevention of ASCVD
A Scientific Statement from the National Lipid Association
Carl E. Orringer, MD, FNLA, Michael J. Blaha, MD, MPH, Ron Blankstein, MD, Matthew J Budoff, MD, Ronald B. Goldberg, MD, FNLA, Edward A. Gill, MD, FNLA, Kevin C. Maki, PhD, CLS, FNLA, Laxmi Mehta, MD, FNLA, Terry A. Jacobson, MD, FNLA
CAC scoring strongly informs ASCVD risk discrimination and reclassification.
CAC scoring aids in ASCVD risk prediction, regardless of race, gender or ethnicity.
CAC scoring aids the clinician to allocate statin therapy based on ASCVD risk.
Very high CAC scores may inform decision-making about add-on therapies to statins.
CAC scoring aids decision-making about aspirin and anti-hypertensive therapy.